Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM.

Hepatology. 2007 Apr;45(4):938-47.

PMID:
17393520
2.

Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.

Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.

Liver Transpl. 2004 May;10(5):607-20.

3.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
4.

Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.

Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.

Ann Surg Oncol. 2006 Jul;13(7):947-54. Epub 2006 May 23.

PMID:
16788756
5.

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, Buonaguro L, Marincola FM, Wang E, Buonaguro FM.

J Transl Med. 2009 Oct 12;7:85. doi: 10.1186/1479-5876-7-85.

6.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
7.

Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.

Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, Fisher R.

Mol Med. 2009 Mar-Apr;15(3-4):85-94. doi: 10.2119/molmed.2008.00110. Epub 2008 Dec 15.

8.

Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.

Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.

Int J Oncol. 2006 Aug;29(2):315-27.

PMID:
16820872
9.

Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.

Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.

Int J Oncol. 2008 Nov;33(5):949-58.

PMID:
18949357
10.

Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.

van Dekken H, Wink J, Alers JC, de Man RA, IJzermans JN, Zondervan PE.

Acta Histochem. 2003;105(1):29-41.

PMID:
12666986
11.

Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.

Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.

J Gastroenterol Hepatol. 2009 Mar;24(3):416-28. doi: 10.1111/j.1440-1746.2008.05699.x. Epub 2008 Nov 27.

PMID:
19054267
12.

Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.

Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.

Int J Oncol. 2006 Feb;28(2):383-91.

PMID:
16391793
13.

Functional genomic studies: insights into the pathogenesis of liver cancer.

Han ZG.

Annu Rev Genomics Hum Genet. 2012;13:171-205. doi: 10.1146/annurev-genom-090711-163752. Epub 2012 Jun 11. Review.

PMID:
22703171
14.

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.

Zhang H, Zhu C, Zhao Y, Li M, Wu L, Yang X, Wan X, Wang A, Zhang MQ, Sang X, Zhao H.

Oncotarget. 2015 Dec 22;6(41):43770-8. doi: 10.18632/oncotarget.6087.

15.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
16.

Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.

Tsunedomi R, Iizuka N, Yamada-Okabe H, Tamesa T, Okada T, Sakamoto K, Takashima M, Hamaguchi T, Miyamoto T, Uchimura S, Hamamoto Y, Yamada M, Oka M.

Int J Oncol. 2006 Dec;29(6):1445-51.

PMID:
17088983
17.

Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.

Zheng S, Tansey WP, Hiebert SW, Zhao Z.

BMC Med Genomics. 2011 Aug 8;4:62. doi: 10.1186/1755-8794-4-62.

18.

Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.

Lee SY, Song KH, Koo I, Lee KH, Suh KS, Kim BY.

Genomics. 2012 Jun;99(6):347-54. doi: 10.1016/j.ygeno.2012.04.004. Epub 2012 Apr 29.

19.

Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.

Hass HG, Jobst J, Vogel U, Scheurlen M, Nehls O.

Oncol Res Treat. 2014;37(12):732-8. doi: 10.1159/000369151. Epub 2014 Nov 21.

PMID:
25531719
20.

Early molecular and genetic determinants of primary liver malignancy.

Feitelson MA, Pan J, Lian Z.

Surg Clin North Am. 2004 Apr;84(2):339-54. Review.

PMID:
15062649

Supplemental Content

Support Center